Perrigo Total Assets 2006-2018 | PRGO

Perrigo total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Perrigo total assets for the quarter ending December 31, 2018 were $10.983B, a 5.55% decline year-over-year.
  • Perrigo total assets for 2018 were $10.983B, a 5.55% decline from 2017.
  • Perrigo total assets for 2017 were $11.629B, a 16.16% decline from 2016.
  • Perrigo total assets for 2016 were $13.87B, a 28.32% decline from 2015.
Perrigo Annual Total Assets
(Millions of US $)
2018 $10,983
2017 $11,629
2016 $13,870
2015 $19,350
2015 $19,592
2014 $13,853
2013 $5,351
2012 $4,024
2011 $3,189
2010 $3,109
2009 $2,443
2008 $2,578
2007 $1,925
2006 $1,751
2005 $1,705
Perrigo Quarterly Total Assets
(Millions of US $)
Q4 2018 $10,983
Q3 2018 $10,943
Q2 2018 $11,226
Q1 2018 $11,640
Q4 2017 $11,629
Q3 2017 $11,843
Q2 2017 $11,792
Q1 2017 $13,979
Q4 2016 $13,870
Q3 2016 $15,888
Q2 2016 $18,291
Q1 2016 $19,500
Q4 2015 $19,350
Q3 2015 $19,703
Q2 2015 $19,721
Q1 2015 $16,183
Q4 2014 $16,461
Q3 2014 $13,781
Q2 2014 $13,880
Q1 2014 $13,743
Q4 2013 $13,713
Q3 2013 $5,509
Q2 2013 $5,351
Q1 2013 $4,496
Q4 2012 $4,294
Q3 2012 $4,117
Q2 2012 $4,024
Q1 2012 $4,040
Q4 2011 $3,943
Q3 2011 $3,514
Q2 2011 $3,189
Q1 2011 $3,037
Q4 2010 $2,935
Q3 2010 $2,772
Q2 2010 $3,109
Q1 2010 $2,489
Q4 2009 $2,459
Q3 2009 $2,407
Q2 2009 $2,536
Q1 2009 $2,372
Q4 2008 $2,428
Q3 2008 $2,505
Q2 2008 $2,581
Q1 2008 $2,199
Q4 2007 $2,039
Q3 2007 $1,947
Q2 2007 $1,925
Q1 2007 $1,891
Q4 2006 $1,854
Q3 2006 $1,816
Q2 2006 $1,751
Q1 2006 $1,671
Q4 2005 $1,684
Q3 2005 $1,691
Q2 2005 $1,705
Q1 2005 $1,731
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.633B $4.732B
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71